We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 4,337

Colorado Supreme Court permits employers to enforce zero-tolerance drug policies against medical cannabis users
  • Jones Day
  • USA
  • June 26 2015

On June 15, 2015, the Colorado Supreme Court held that Colorado employers can enforce zero-tolerance drug policies against employees who are


Cyber insurance for fines and penalties part II self-regulating organization assessments, including PCI-DSS fines and penalties
  • Jones Day
  • USA
  • June 24 2015

In our last post we addressed cyber coverage for fines and penalties imposed by governmental authorities. In this post, we discuss coverage for


Food, dietary supplement & cosmetics regulatory update volume II, issue 13
  • Jones Day
  • Canada, European Union, USA
  • June 24 2015

Last week, FDA finalized its determination that partially hydrogenated oils ("PHOs") are not "generally recognized as safe" ("GRAS") for use in human


Federal Circuit upends presumption for means-plus-function claiming
  • Jones Day
  • USA
  • June 23 2015

Since at least 1998, the Federal Circuit has held that when a patent uses the word "means" in a claim element, that creates a "rebuttable


Merger Control in the United Kingdom
  • Jones Day
  • Global, United Kingdom
  • June 23 2015

A structured guide to merger control laws and practice in the United Kingdom


Supreme Court of Texas issues three important oil and gas decisions
  • Jones Day
  • USA
  • June 23 2015

This month, the Texas Supreme Court decided three cases implicating oil and gas contract interpretation issues with important consequences to the


Recent developments in regulations governing the manufacturing and marketing of induced pluripotent stem cells
  • Jones Day
  • Japan
  • June 22 2015

It is now permissible to launch regenerative products for medical use in humans or animals, including iPS cells, by using the fast-track approval


Top three revisions to key ITAR definitions proposed by Department of State; comments invited
  • Jones Day
  • USA
  • June 22 2015

The U.S. Department of State, Directorate of Defense Trade Controls ("DDTC") recently published proposed revisions to the International Traffic in


Amendment of rules applicable to French branches of non-European banks
  • Jones Day
  • European Union, France
  • June 22 2015

A bank that has its registered office outside the European Economic Area ("EEA") may consider establishing a presence in France in order to provide


French financial institutions litigation & regulation update, issue 9
  • Jones Day
  • European Union, France
  • June 22 2015

Pursuant to Article 47(1) of CRD IV, Ordinance no. 2015-558 dated May, 21, 2015 amended with immediate effect the provisions applying to French